SCID (TREC) (Not yet available)
Detection of TREC levels by qPCR (KIT still in development and not yet available).
The Human SCID detection KIT is an in vitro diagnostic KIT as primary screening method for the detection of SCID (Severe Combined Immunodeficiency) by qPCR. This assay is dedicated to professional use in diagnostic laboratory. The device is not for self-testing.
Severe Combined Immunodeficiency Disease (SCID) is a condition in which there are no or abnormally low levels of T cells and/or low, high or normal numbers of B cells and NK cells. The prevalence is 1/50-100,000 newborns. In the absence of treatment, early signs of the disease begin to appear during the first few months of life and may include :
Babies with SCID are protected by their mother's immune system for a short period of time after birth. Neonatal screening for SCID before symptoms appear makes it possible to perform a bone marrow transplant and thus save the newborn.
Feel free to contact us !